Advertisement

Granulocyte and Monocyte Chemotactic Factors: Stimuli and Producer Cells

  • Jo Van Damme
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 305)

Abstract

The interest of our laboratory in cytokine production by various cell types originates from the early observation that different types of interferon (IFN) are released, depending on the inducer and cell type used. Indeed, infection of leukocytes with virus results in production of IFN-α (formerly leukocyte IFN), whereas fibroblasts release IFN-β (formerly fibroblast IFN) in response to double-stranded RNA (dsRNA) or virus (1). Further studies on IFN allowed us to discover a leukocyte-derived protein, that exerts an indirect antiviral activity through IFN-β induction on fibroblasts. The molecule involved could be identified as interleukin-lβ (IL-1β) (2), now well known as an inducer of other cytokines such as IL-6 (3). In contrast to IFN, IL-6 exists as a single molecular species, but can be induced in a variety of cells, including fibroblasts and leukocytes. These cell types also produce granulocyte (GCP/IL-8) and monocyte (MCP) chemotactic proteins in response to IL-1, other cytokines and cytokine inducers (Table 1). In addition, different tumor cell lines are capable of releasing these chemotactic molecules.

Keywords

Measle Virus Chemotactic Factor Human Dermal Fibroblast Chemotactic Activity Diploid Fibroblast 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Havell, E.A., B. Berman, C.A. Ogburn, K. Berg, K. Paucker and J. Vilcek. 1975. Two antigenically distinct species of human interferon, Proc. Natl. Acad. Sci. USA 72: 2185–2187.PubMedCrossRefGoogle Scholar
  2. 2.
    Van Damme, J., M. De Ley, G. Opdenakker, A. Billiau, P. De Somer and J. Van Beeumen. 1985. Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1, Nature 314: 266–268.PubMedCrossRefGoogle Scholar
  3. 3.
    Van Damme, J., G. Opdenakker, R.J. Simpson, M.R. Rubira, S. Cayphas, A. Vink, A. Billiau and J. Van Snick. 1987. Identification of the human 26-kD protein, interferon β-2 (IFN-β2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor, J. Exp. Med. 165: 914–919.PubMedCrossRefGoogle Scholar
  4. 4.
    Schmid, J. and C. Weissmann. 1987. Induction of mRNA for a serine protease and a β-thromboglobulin-like protein in mitogen-stimulated human leukocytes, J. Immunol. 139: 250–256.PubMedGoogle Scholar
  5. 5.
    Yoshimura, T., K. Matsushima, S. Tanaka, E.A. Robinson, E. Appella, J.J. Oppenheim and EJ. Leonard. 1987. Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines, Proc. Natl. Acad. Sci. USA 84: 9233–9237.PubMedCrossRefGoogle Scholar
  6. 6.
    Schröder, J.-M., U. Mrowietz, E. Morita and E. Christophers. 1987. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil-activating peptide that lacks interleukin 1 activity, J. Immunol. 139: 3474–3483.PubMedGoogle Scholar
  7. 7.
    Peveri, P., A. Walz, B. Dewald and M. Baggiolini. 1988. A novel neutrophil-activating factor produced by human mononuclear phagocytes, J. Exp. Med. 167: 1547–1559.PubMedCrossRefGoogle Scholar
  8. 8.
    Van Damme, J., J. Van Beeumen, G. Opdenakker and A. Billiau. 1988. A novel, NH2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J. Exp. Med. 167: 1364–1376.PubMedCrossRefGoogle Scholar
  9. 9.
    Matsushima, K., K. Morishita, T. Yoshimura, S. Lavu, Y. Kobayashi, W. Lew, E. Appella, H.F. Kung, EJ. Leonard and JJ. Oppenheim. 1988. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor, J. Exp. Med. 167: 1883–1893.PubMedCrossRefGoogle Scholar
  10. 10.
    Gregory, H., J. Young, J.-M. Schröder, U. Mrowietz and E. Christophers. 1988. Structure determination of a human lymphocyte derived neutrophil activating peptide (LYNAP), Biochem. Biophys. Res. Commun. 151: 883–890.PubMedCrossRefGoogle Scholar
  11. 11.
    Schröder, J.-M., U. Mrowietz and E. Christophers. 1988. Purification and partial biologic characterization of a human lymphocyte-derived peptide with potent neutrophil-stimulating activity, J. Immunol. 140: 3534–3540.PubMedGoogle Scholar
  12. 12.
    Van Damme, J., B. Decock, R. Conings, J.-P. Lenaerts, G. Opdenakker and A. Billiau. 1989. The chemotactic activity for granulocytes produced by virally infected fibroblasts is identical to monocyte-derived interleukin 8, Eur. J. Immunol. 19: 1189–1194.Google Scholar
  13. 13.
    Strieter, R.M., S.H. Phan, HJ. Showell, D.G. Remick, J.P. Lynch, M. Genord, C. Raiford, M. Eskandari, R.M. Marks and S.L. Kunkel. 1989. Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J. Biol. Chem. 264: 10621–10626.PubMedGoogle Scholar
  14. 14.
    Schröder, J.-M., M. Sticherling, H.H. Henneicke, W.G. Preissner and E. Christophers. 1990. IL-1α or tumor necrosis factor-α stimulate release of three NAP-l/IL-8-related neutrophil chemotactic proteins in human dermal fibroblasts, J. Immunol. 144: 2223–2232.PubMedGoogle Scholar
  15. 15.
    Schröder, J.M. and E. Christophers. 1989. Secretion of novel and homologous neutrophil-activating peptides by LPS-stimulated human endothelial cells, J. Immunol. 142: 244–251.PubMedGoogle Scholar
  16. 16.
    Strieter, R.M., S.L. Kunkel, HJ. Showell, D.G. Remick, S.H. Phan, P.A. Ward and R.M. Marks. 1989. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β, Science 243: 1467–1469.PubMedCrossRefGoogle Scholar
  17. 17.
    Gimbrone Jr., M.A., M.S. Obin, A.F. Brock, E.A. Luis, P.E. Hass, CA. Hbert, Y.K. Yip, D.W. Leung, D.G. Lowe, W.J. Kohr, W.C. Darbonne, K.B. Bechtol and J.B. Baker. 1989. Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions, Science 246: 1601–1603.PubMedCrossRefGoogle Scholar
  18. 18.
    Sica, A., K. Matsushima, J. Van Damme, J.M. Wang, N. Polentarutti, E. Dejana, F. Colotta and A. Mantovani. 1990. IL-1 transcriptionally activates the neutrophil chemotactic factor/IL-8 gene in endothelial cells, Immunology 69: 548–553.PubMedGoogle Scholar
  19. 19.
    Van Damme, J., R.A.D. Bunning, R. Conings, R. Graham, G. Russell and G. Opdenakker. 1990. Characterization of granulocyte chemotactic activity from human cytokine-stimulated chondrocytes as interleukin 8. Cytokine 2: 106–111.PubMedCrossRefGoogle Scholar
  20. 20.
    Golds, E.E., P. Mason and P. Nyirkos. 1989. Inflammatory cytokines induce synthesis and secretion of gro protein and a neutrophil chemotactic factor but not β2-microglobulin in human synovial cells and fibroblasts, Biochem. J. 259: 585–588.PubMedGoogle Scholar
  21. 21.
    Larsen, CG., A.O. Anderson, J.J. Oppenheim and K. Matsushima. 1989. Production of interleukin-8 by human dermal fibroblasts and keratinocytes in response to interleukin-1 or tumour necrosis factor, Immunology 68: 31–36.PubMedGoogle Scholar
  22. 22.
    Barker, J.N.W.N., V. Sarma, R.S. Mitra, V.M. Dixit and BJ. Nickoloff. 1990. Marked synergism between tumor necrosis factor-α and interferon- in regulation of keratinocyte-derived adhesion molecules and chemotactic factors, J. Clin. Invest. 85: 605–608.PubMedCrossRefGoogle Scholar
  23. 23.
    Einer, V.M., R.M. Strieter, S.G. Einer, M. Baggiolini, I. Lindley and S.L. Kunkel. 1990. Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells, Am. J. Pathol. 136: 745–750.Google Scholar
  24. 24.
    Kowalski, J. and D.T. Denhardt. 1989. Regulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 promyelocytes, Mol. Cell. Biol. 9: 1946–1957.PubMedGoogle Scholar
  25. 25.
    Suzuki, K., H. Miyasaka, H. Ota, Y. Yamakawa, M. Tagawa, A. Kuramoto and S. Mizuno. 1989. Purification and partial primary sequence of a chemotactic protein for polymorphonuclear leukocytes derived from human lung giant cell carcinoma LU65C cells, J. Exp. Med. 169: 1895–1901.PubMedCrossRefGoogle Scholar
  26. 26.
    Thornton, A.J., R.M. Strieter, I. Lindley, M. Baggiolini and S.L. Kunkel. 1990. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 in human hepatocytes, J. Immunol. 144: 2609–2613.PubMedGoogle Scholar
  27. 27.
    Van Damme, J., B. Decock, J.-P. Lenaerts, R. Conings, R. Bertini, A. Mantovani and A. Billiau. 1989. Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine, Eur. J. Immunol. 19: 2367–2373.PubMedCrossRefGoogle Scholar
  28. 28.
    Yoshimura, T., N. Yuhki, S.K. Moore, E. Appella, M.I. Lerman and E.J. Leonard. 1989. Human monocyte chemoattractant protein-1 (MCP-1). FEBS Letts. 244: 487–493.CrossRefGoogle Scholar
  29. 29.
    Furutani, Y., H. Nomura, M. Notake, Y. Oyamada, T. Fukui, M. Yamada, C.G. Larsen, J.J. Oppenheim and K. Matsushima. 1989. Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF), Biochem. Biophys. Res. Commun. 159: 249–255.PubMedCrossRefGoogle Scholar
  30. 30.
    Decock, B., R. Conings, J.-P. Lenaerts, A. Billiau and J. Van Damme. 1990. Identification of the monocyte chemotactic protein from human osteosarcoma cells and monocytes: detection of a novel N-terminally processed form, Biochem. Biophys. Res. Commun. 167: 904–909.PubMedCrossRefGoogle Scholar
  31. 31.
    Yoshimura, T., E.A. Robinson, S. Tanaka, E. Appella and EJ. Leonard. 1989. Purification and amino acid analysis of two human monocyte chemoattractants produced by phytohemagglutinin-stimulated human blood mononuclear leukocytes, J. Immunol. 142: 1956–1962.PubMedGoogle Scholar
  32. 32.
    Rollins, B.J., P. Stier, T. Ernst and G.G. Wong. 1989. The human homolog of the JE gene encodes a monocyte secretory protein, Mol. Cell. Biol. 9:4687–4695.PubMedGoogle Scholar
  33. 33.
    Introna, M., R.C. Bast Jr., C.S. Tannenbaum, T.A. Hamilton and D.O. Adams. 1987. The effect of LPS on expression of the early “competence” genes JE and KC in murine peritoneal macrophages, J. Immunol. 138: 3891–3896.PubMedGoogle Scholar
  34. 34.
    Prpic, V., S.-F. Yu, F. Figueiredo, P.W. Hollenbach, G. Gawdi, B. Herman, RJ. Uhing and D.O. Adams. 1989. Role of Na + /H + exchange by interferon-. in enhanced expression of JE and I-Aβ genes, Science 244: 469–471.PubMedCrossRefGoogle Scholar
  35. 35.
    Rollins, B.J., E.D. Morrison, and C.D. Stiles. 1988. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties, Proc. Natl. Acad. Sci. USA 85: 3738–3742.PubMedCrossRefGoogle Scholar
  36. 36.
    C.G. Larsen, C.O.C. Zachariae, J.J. Oppenheim and K. Matsushima. 1989. Production of monocyte chemotactic and activating factor (MCAF) by human dermal fibroblasts in response to interleukin 1 or tumor necrosis factor, Biochem. Biophys. Res. Commun. 160: 1403–1408.PubMedCrossRefGoogle Scholar
  37. 37.
    Strieter, R.M., R. Wiggins, S.H. Phan, B.L. Wharram, HJ. Showell, D.G. Remick, S.W. Chensue and S.L. Kunkel. 1989. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells, Biochem. Biophys. Res. Commun. 162: 694–700.PubMedCrossRefGoogle Scholar
  38. 38.
    Sica, A., J.M. Wang, F. Colotta, E. Dejana, A. Mantovani, JJ. Oppenheim, C.G. Larsen, C.O.C Zachariae and K. Matsushima. 1990. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor, J. Immunol. 144: 3034–3038.PubMedGoogle Scholar
  39. 39.
    Takehara, K., E.C. LeRoy and G.R. Grotendorst. 1987. TGF-β inhibition of endothelial cell proliferation: alteration of EGF binding and EGF-induced growth-regulatory (competence) gene expression, Cell 49: 415–422.PubMedCrossRefGoogle Scholar
  40. 40.
    Valente, A.J., D.T. Graves, C.E. Vialle-Valentin, R. Delgado and C.J. Schwartz. 1988. Purification of a monocyte chemotactic factor secreted by nonhuman primate vascular cells in culture, Biochemistry 27: 4162–4168.PubMedCrossRefGoogle Scholar
  41. 41.
    Matsushima, K., C.G. Larsen, G.C. DuBois and J.J. Oppenheim. 1989. Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line, J. Exp. Med. 169: 1485–1490.PubMedCrossRefGoogle Scholar
  42. 42.
    Graves, D.T., Y.L. Jiang, M.J. Williamson and A.J. Valente. 1989. Identification of monocyte chemotactic activity produced by malignant cells, Science 245: 1490–1493.PubMedCrossRefGoogle Scholar
  43. 43.
    Bottazzi, B., F. Colotta, A. Sica, N. Nobili and A. Mantovani. 1990. A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF), Int. J. Cancer 45: 795–797.PubMedCrossRefGoogle Scholar
  44. 44.
    Yoshimura, T., E.A. Robinson, S. Tanaka, E. Appella, J.-I. Kuratsu and E.J. Leonard. 1989. Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants, J. Exp. Med. 169: 1449–1459.PubMedCrossRefGoogle Scholar
  45. 45.
    Nelson, R.D., P.G. Quie and R.L. Simmons. 1975. Chemotaxis under agarose: a new and simple method for measuring Chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes, J. Immunol. 115: 1650–1656.PubMedGoogle Scholar
  46. 46.
    Westwick, J., S.W. Li and R.D. Camp. 1989. Novel neutrophil-stimulating peptides, Immunol. Today 10: 146–147.PubMedCrossRefGoogle Scholar
  47. 47.
    Van Damme, J., M.R. Schaafsma, W.E. Fibbe, J.H.F. Falkenburg, G. Opdenakker and A. Billiau. 1989. Simultaneous production of interleukin 6, interferon-β and colony-stimulating activity by fibroblasts after viral and bacterial infection. Eur. J. Immunol. 19: 163–168.PubMedCrossRefGoogle Scholar
  48. 48.
    Strieter, R.M., S.W. Chensue, TJ. Standiford, M.A. Basha, HJ. Showell and S.L. Kunkel. 1990. Disparate gene expression of chemotactic cytokines by human mononuclear phagocytes, Biochem. Biophys. Res. Commun. 166: 886–891.PubMedCrossRefGoogle Scholar
  49. 49.
    Rampart, M., J. Van Damme, L. Zonnekeyn and A.G. Herman. 1989. Granulocyte chemotactic protein/interleukin-8 induces plasma leakage and neutrophil accumulation in rabbit skin. Am. J. Pathol. 135: 21–25.PubMedGoogle Scholar
  50. 50.
    Bottazzi, B., N. Polentarutti, R. Acero, A. Balsari, D. Boraschi, P. Ghezzi, M. Salmona and A. Mantovani. 1983. Regulation of the macrophage content of neoplasms by chemoattractants, Science 220: 210–212.PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1991

Authors and Affiliations

  • Jo Van Damme
    • 1
  1. 1.Rega InstituteUniversity of LeuvenLeuvenBelgium

Personalised recommendations